FIT Biotech Releases Immunomodulator FIT-06 Study Results – Pharmaceutical Business Review
![]() The Hindu |
FIT Biotech Releases Immunomodulator FIT-06 Study Results
Pharmaceutical Business Review This is expected to be an alternative to antiretroviral therapy (ART) for HIV-infected patients. FIT-06 is a DNA-based vaccine developed by FIT Biotech … Phase II Data from FIT Biotech's HIV Immunotherapy Show Reduction in Viral … |










